[DPHARMA] QoQ Annualized Quarter Result on 31-Mar-2015 [#1]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
18-May-2015
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2015
Quarter
31-Mar-2015 [#1]
Profit Trend
QoQ- 1.72%
YoY- 7.22%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
Revenue 270,680 241,705 203,814 182,396 176,961 167,916 162,236 40.54%
PBT 49,755 42,968 41,210 48,792 46,509 43,452 42,604 10.86%
Tax 0 -11,714 -11,576 -12,916 0 -10,685 -10,820 -
NP 49,755 31,253 29,634 35,876 46,509 32,766 31,784 34.70%
-
NP to SH 38,775 31,253 29,634 35,876 35,271 32,766 31,784 14.13%
-
Tax Rate 0.00% 27.26% 28.09% 26.47% 0.00% 24.59% 25.40% -
Total Cost 220,925 210,452 174,180 146,520 130,452 135,149 130,452 41.94%
-
Net Worth 270,177 268,509 190,284 205,045 192,942 187,436 179,045 31.46%
Dividend
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
Div 15,843 - 11,193 - 25,679 7,404 11,103 26.66%
Div Payout % 40.86% - 37.77% - 72.81% 22.60% 34.93% -
Equity
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
Net Worth 270,177 268,509 190,284 205,045 192,942 187,436 179,045 31.46%
NOSH 278,959 278,959 139,915 139,486 138,807 138,841 138,794 59.05%
Ratio Analysis
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
NP Margin 18.38% 12.93% 14.54% 19.67% 26.28% 19.51% 19.59% -
ROE 14.35% 11.64% 15.57% 17.50% 18.28% 17.48% 17.75% -
Per Share
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
RPS 162.30 144.93 145.67 130.76 127.49 120.94 116.89 24.38%
EPS 19.17 18.72 21.18 25.72 25.41 23.60 22.90 -11.14%
DPS 9.50 0.00 8.00 0.00 18.50 5.33 8.00 12.10%
NAPS 1.62 1.61 1.36 1.47 1.39 1.35 1.29 16.35%
Adjusted Per Share Value based on latest NOSH - 139,486
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
RPS 28.14 25.13 21.19 18.96 18.40 17.46 16.87 40.51%
EPS 4.03 3.25 3.08 3.73 3.67 3.41 3.30 14.20%
DPS 1.65 0.00 1.16 0.00 2.67 0.77 1.15 27.12%
NAPS 0.2809 0.2791 0.1978 0.2132 0.2006 0.1949 0.1861 31.48%
Price Multiplier on Financial Quarter End Date
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
Date 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 -
Price 2.62 2.72 2.65 3.88 2.50 3.17 2.97 -
P/RPS 1.61 1.88 1.82 2.97 1.96 2.62 2.54 -26.14%
P/EPS 11.27 14.51 12.51 15.09 9.84 13.43 12.97 -8.91%
EY 8.87 6.89 7.99 6.63 10.16 7.44 7.71 9.76%
DY 3.63 0.00 3.02 0.00 7.40 1.68 2.69 22.04%
P/NAPS 1.62 1.69 1.95 2.64 1.80 2.35 2.30 -20.78%
Price Multiplier on Announcement Date
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
Date 23/02/16 24/11/15 25/08/15 18/05/15 24/02/15 21/11/14 26/08/14 -
Price 2.61 2.70 2.40 3.90 2.92 3.01 3.37 -
P/RPS 1.61 1.86 1.65 2.98 2.29 2.49 2.88 -32.06%
P/EPS 11.23 14.41 11.33 15.16 11.49 12.75 14.72 -16.46%
EY 8.91 6.94 8.83 6.59 8.70 7.84 6.80 19.68%
DY 3.64 0.00 3.33 0.00 6.34 1.77 2.37 33.01%
P/NAPS 1.61 1.68 1.76 2.65 2.10 2.23 2.61 -27.47%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment